Henry Schein - HSIC Stock Forecast, Price & News

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last year. There are currently 1 sell rating, 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HSIC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HSIC, but not buy additional shares or sell existing shares.
View HSIC analyst ratings or view top-rated stocks.

8 brokers have issued 12 month price objectives for Henry Schein's shares. Their HSIC share price forecasts range from $72.00 to $99.00. On average, they anticipate the company's stock price to reach $84.67 in the next year. This suggests a possible upside of 1.7% from the stock's current price.
View analysts price targets for HSIC or view top-rated stocks among Wall Street analysts.

Henry Schein's stock was trading at $77.53 on January 1st, 2022. Since then, HSIC stock has increased by 7.4% and is now trading at $83.29.
View the best growth stocks for 2022 here.

Henry Schein saw a increase in short interest in November. As of November 15th, there was short interest totaling 5,290,000 shares, an increase of 6.0% from the October 31st total of 4,990,000 shares. Based on an average daily volume of 997,300 shares, the days-to-cover ratio is presently 5.3 days. Approximately 4.0% of the shares of the stock are sold short.
View Henry Schein's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 21st 2023.
View our HSIC earnings forecast.

Henry Schein, Inc. (NASDAQ:HSIC) released its earnings results on Tuesday, November, 2nd. The company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.16. The firm earned $3.18 billion during the quarter, compared to analyst estimates of $2.94 billion. Henry Schein had a net margin of 5.06% and a trailing twelve-month return on equity of 15.48%. During the same quarter in the previous year, the company posted $1.03 EPS.
Read the conference call transcript.

Henry Schein's stock split on the morning of Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly minted shares were payable to shareholders after the closing bell on Thursday, September 14th 2017. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Henry Schein announced that its Board of Directors has authorized a stock repurchase program on Thursday, August 18th 2022, which permits the company to repurchase $400,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy up to 4% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's board believes its stock is undervalued.

Henry Schein updated its FY 2022 earnings guidance on Tuesday, November, 8th. The company provided earnings per share (EPS) guidance of $4.79-$4.87 for the period, compared to the consensus EPS estimate of $4.84. The company issued revenue guidance of $12.59 billion-$12.71 billion, compared to the consensus revenue estimate of $12.89 billion.

451 employees have rated Henry Schein Chief Executive Officer Stanley M. Bergman on Glassdoor.com. Stanley M. Bergman has an approval rating of 94% among the company's employees. This puts Stanley M. Bergman in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Henry Schein investors own include Alibaba Group (BABA), Pfizer (PFE), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM), CVS Health (CVS), Micron Technology (MU) and AT&T (T).

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

Henry Schein's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (11.53%), BlackRock Inc. (7.81%), Longview Partners Guernsey LTD (5.23%), State Street Corp (5.12%), Pendal Group Ltd (3.24%) and Macquarie Group Ltd. (1.80%). Insiders that own company stock include Deborah Derby, Gerald A Benjamin, James P Breslawski, James P Breslawski, Kurt P Kuehn, Mark E Mlotek, Michael S Ettinger, Scott Philip Serota, Stanley M Bergman, Steven Paladino and Walter Siegel.
View institutional ownership trends.

Shares of HSIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of HSIC stock can currently be purchased for approximately $83.29.

Henry Schein (NASDAQ:HSIC) has a market capitalization of $11.29 billion and generates $12.40 billion in revenue each year. The company earns $631.23 million in net income (profit) each year or $4.60 on an earnings per share basis.

The company employs 21,600 workers across the globe.

Henry Schein's mailing address is 135 DURYEA RD, MELVILLE NY, 11747. The official website for the company is www.henryschein.com. The company can be reached via phone at (631) 843-5500, via email at steven.paladino@henryschein.com, or via fax at 631-843-5541.